Skip to main content
Premium Trial:

Request an Annual Quote

Peter Barrett, Lee Hood, Patricia Sueltz


Peter Barrett, a co-founder of Celera Genomics and executive vice president and chief business officer of the company, has joined Boston, Mass.-based venture capital firm Atlas Venture, where he will lead the firm’s investments in US life science companies.

Barrett’s replacement will be David Block, who was appointed executive vice president of Celera and chief operating officer of the Rockville, Md.-based company’s therapeutics business last week.

Block, who most recently served as executive vice president for international operations at DuPont Pharmaceuticals, will join the company on February 1, 2002, and will report to Craig Venter, Celera’s president and chief scientific officer.


Paradigm Genetics of Research Triangle Park, NC, has named Lee Hood — president and director of Seattle’s Institute for Systems Biology — to its board of directors.

“Paradigm Genetics is a pioneer in the emerging science of metabolomics, and I am delighted to join them in their efforts,” said Hood in a statement.

In addition to his current position with the ISB, Hood is a professor at large for the Keck Graduate Institute of Applied Life Sciences and an affiliate professor of the University of Washington’s bioengineering, computer science, and immunology departments.


Thousand Oaks, Calif.-based Amgen has elected Patricia Sueltz, executive vice president and general manager of Sun Microsystems’ Software Systems Group, to its board of directors.

“Patricia Sueltz’s experience in managing fast-growing, information-intensive companies will be important to Amgen as we grow and become more information management dependent ourselves,” said Kevin Sharer, Amgen’s chairman and chief executive officer, in a statement.

Filed under

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.